Early signs of how each side could fare at trial in hundreds of suits over contrasting agents that allegedly cause nephrogenic systemic fibrosis are expected to come out of a California court. A suit against Bayer Healthcare Pharmaceuticals has been assigned to begin trial in January in San Francisco Superior Court. The suit accuses Bayer of negligently designing, testing and marketing a drug used to help doctors read MRIs. According to a lawyer in the case, the suit is the first to be scheduled for trial over the drug.
Bayer's Multimillion-Dollar MRI-Related Drug to Get Its First Trial Test
December 9, 2009